Healthy Skepticism Library item: 3300
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
 
Publication type: news
MLAM letter update
MLAM Newsletter 1985 Apr 01
Abstract:
As a result of a MaLAM letter Ciba-Geigy has agreed to restrict promotion of phenylbutazone to a few specific conditions.
Keywords:
*news story/developing countries/Ciba-Geigy/phenylbutazone/NSAID/ nonsteroidal anti-inflammatory drugs/MaLAM/Medical Lobby for Appropriate Marketing/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES/REGULATION, CODES, GUIDELINES: FEEDBACK TO COMPANIES